Apoptosis: a general commentAjit J. Alles, H. R. Warner, Keith E. Alley et al.|The FASEB Journal|1991Cited by 81
NRF2 activation by reversible KEAP1 binding induces the antioxidant response in primary neurons and astrocytes of a Huntington's disease mouse modelDaniele Moretti, Alberto Bresciani, Sara Tambone et al.|Free Radical Biology and Medicine|2020Cited by 49
Nuclear factor (erythroid-derived 2)-like 2 (NRF2) drug discovery: Biochemical toolbox to develop NRF2 activators by reversible binding of Kelch-like ECH-associated protein 1 (KEAP1)Alberto Bresciani, Larry C. Park, Mauro Cerretani et al.|Archives of Biochemistry and Biophysics|2017Cited by 45
Optimization of linear and cyclic peptide inhibitors of KEAP1-NRF2 protein-protein interactionStefania Colarusso, Elisabetta Bianchi, Daniele De Simone et al.|Bioorganic & Medicinal Chemistry|2020Cited by 27
SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 proteaseStefania Colarusso, Jesus M. Ontoria, Federica Ferrigno et al.|Bioorganic & Medicinal Chemistry|2022Cited by 11